Getting drugs to market faster through better health data management on AWS

The article discusses how the healthcare and life sciences industry can adopt the principles of data mesh and "data as a product" (DaaP) to improve data management and accelerate the process of drug discovery and delivery to patients.

Specifically, the article covers:

• The data challenges and opportunities in the healthcare and life sciences industry, particularly in ensuring faster availability of new and generic drugs to patients.
• The concept of data mesh, which involves decentralized, domain-driven data management, and the four principles of data mesh: data as a product, domain-driven ownership, self-service data infrastructure, and federated computational governance.
• The DaaP approach, which treats data as a valuable asset and product, and its key aspects like product mindset, data governance, data productization, data marketplace, continuous improvement, and monetization.
• The characteristics of DaaP, such as quality, discoverability, usability, interoperability, security and privacy, and scalability.
• How AWS services like Amazon DataZone and AWS Lake Formation can enable the implementation of DaaP and data mesh principles, helping organizations comply with regulations like HIPAA and ISO 27001.
• Architectural considerations for implementing DaaP, including architectural quantum, temporal immutable data, multimodal access, and types of data products.
• Conclusion: Adopting data mesh and DaaP principles can help the healthcare and life sciences industry better manage and leverage data, accelerating the journey of drugs from lab to patient.